Single agent vincristine by infusion in refractory multiple myeloma.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
1984 • 667 citations
Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
1973 • 234 citations
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol
1977 • 222 citations
Clinical Studies with Vincristine
1963 • 143 citations
Combination therapy for multiple myeloma
1977 • 137 citations
Expansion of the growth fraction in multiple myeloma with alkylating agents
1975 • 96 citations
Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
1979 • 90 citations
Initial clinical studies with vincristine.
1962 • 62 citations
Intravenous vincristine infusion: Phase I trial
1981 • 58 citations
Pharmacokinetics of vincristine infusion.
1981 • 41 citations
Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion
1984 • 41 citations
Augmentation of vincristine neurotoxicity by irradiation of peripheral nerves.
1980 • 24 citations
Antiproliferative effects of corticosteroids in C3H/HeJ Mammary tumors and implications for sequential combination chemotherapy.
1981 • 22 citations
Interaction of albumin and vincristine with a human lymphoblastic leukemia cell line in vitro.
1980 • 3 citations
Cited By (0)
No citing papers found in database